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ABSTRACT 
Master of Philosophy 
Interaction of gold nanoparticles with neurons 
by Agathi Christofidou 
In the last few decades, advances in nanotechnology have resulted in the production and use 
of inorganic nanoparticles (NPs). These NPs have been used commercially for a range of 
applications, particularly in the biomedical field, based on their exceptional chemical and 
physical properties, which are very different to that in the larger scale. Our understanding 
regarding the NP interaction with the cells following NP exposure, prior to their use it is very 
important. This was the motivation for the work carried out in this thesis.  
Initially, the investigation  presented in the thesis involved the synthesis of spherical and 
hollow gold NPs, which were then capped by water soluble organic oligo-ethylene glycol 
ligand (OEG). The OEG-capped NPs were then functionalised by attaching a specific cell 
targeting peptide, lysine terminated-Tet1, on their organic corona. The surface modification 
of the NPs by the aforementioned ligands, was carried out so that the NPs could be employed 
in the biological investigations carried out in this project.  
PC12 and SH-SY5Y cells, neuron-like cell lines, were exposed to the synthesised gold NPs, 
and  the  fate  of  these  NPs  within  the  cells  was  studied  by  using  transmission  electron 
microscopy (TEM). The TEM images revealed that spheres and hollow gold NPs were found 
within the PC12 cells, indicating that they were able to traverse through the cell membrane. 
Though, the pathway and cellular processes involved could not be specifically defined due to 
time constrains. Furthermore, the peptide-functionalised NPs targeted the GTb1 receptors 
which  are  readily  expressed  on  PC12  and  SH-SY5Y  cells.  Lysine  terminated  Tet1-
functionalised NPs uptake seemed to be greater compared to OEG-capped NPs, and they 
were transported to the inner part of the cell around its perinuclear region. Nevertheless, 
further  experiments  involving  fluorescently  tagged  NPs  would  give  us  an  inside  on  the 
cellular events that take place following NP exposure, over time. In addition, western blot  
ii 
analysis of proteins involved in a cell stress response could give us information whether the 
cell is under a stress when it is exposed to gold NPs. 
Furthermore,  the  application  of  the  hyperspectral  darkfield  microscope  designed  by  the 
Muskens group for imaging of single hollow gold NPs on a TEM grid and in a biological 
sample (with fixed SH-SY5Y cells), was also presented in this Thesis. The low illumination 
intensity used (<0:5 W/cm
2) is a very good aspect of this setup for future studies with living 
cells and gold NPs. For example, single hollow gold NPs could be used as spectral sensors of 
a particular cell signalling pathway. 
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1.1  Inorganic Nanoparticles: Exposure and Health impact 
Advances in nanoscience have resulted in the production and use of inorganic nanoparticles 
(NPs).  NPs  are  commercialised  for  a  range  of  applications  (biomedicine,  electronics, 
coatings,  cosmetics,  advanced  materials  and  fuel  additives)  based  on  their  exceptional 
chemical and physical properties (including optical, electronic and magnetic). The unique 
properties of inorganic NPs arise due to their metallic component, small size (diameter <100 
nm) and controlled metrological characteristics, as opposed to the bulk material [1, 2]. NPs 
are highly reactive entities thanks to their high surface area compared to their core (unlike 
micro- and macro- particles).  
The use of inorganic NPs in so many scientific fields has resulted in an exponential rise in 
their production. It has been estimated that between year 2011 and 2020, 58000 tonnes of 
NPs will be produced [3]. Nevertheless, the impact that these NPs have on health and the 
environment has not yet been fully explored [3]. Human exposure to inorganic NPs may 
happen as a result of direct application of products containing NPs, or through NP dispersion 
in the environment during their manufacturing processes and applications. Possible routes of 
NP entry into the human body, include the respiratory tract through inhalation [4], skin by 
translocation of NPs found in cosmetics (ZnO NPs [5]) and blood circulation by intravenous 
administration in nanotherapeutics (gold and magnetic NPs [6]), as illustrated in Figures 1.1 
and 1.2. Cellular uptake and fate of NPs depend on their metrological characteristics, i.e. 
their size, charge, shape and surface coating [7, 8].  Chapter 1. Introduction 
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Figure 1.1. Potential nanoparticle exposure routes from the current commercialised nano-applications. 
Amongst  the  vast  majority  of  inorganic  NPs  available,  gold  NPs  have  been  used 
extensively  in  research,  particularly  in  medical  therapies  [9].  Gold  NPs  have  been  used 
previously as a model system to answer fundamental questions as to how the shape, size and 
functionality of particles influence their fate in cells, as well as how their metrology affects 
functional processes within cells [7, 10]. For example, Hutter et al. found that gold NPs of 
different  morphologies  (spheres,  rods  and  branched  shape)  and  surface  coatings 
(poly(ethylene) glycol, PEG, and Cetyl trimethylammonium bromide, CTAB) had different 
effects on the immunological state of the cells (microglia cells) that constitute the innate 
central nervous system’s immune system [11]. In another study the uptake of gold NPs by 
prostate cancer cells  was  associated with  the different  size (30―60 nm  diameter range), 
shape (spheres and rods) and surface chemistry of gold NPs [12].  
Information  about  the  interaction  of  gold  NPs  with  biological  tissue  is  important 
considering that gold NPs are already in the first stages of clinical trials as part of patients’ 
cancer treatment. In recent clinical trials, gold NPs have been employed as delivery vehicles Chapter 1. Introduction 
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of anti-tumour agents, either directly by targeting a solid tumour (recombinant human tumour 
necrosis  factor  alpha)  or  by  gene  silencing  (siRNA  to  specifically  downregulate  the 
expression  of  RRM2  gene,  which  is  considered  an  anti-cancer  target).  This  study 
demonstrated that anti-tumour agent side effects were reduced, due to the specific targeting 
of tumours and not of healthy tissue [13]. Also, the nanotherapeutics in these clinical trials 
resulted in a stable disease, and in slowing of tumour development for some patients. In these 
trials,  NPs  were  functionalized  with  PEG  for  biostability  and  for  evading  the 
reticuloendothelial system. That is, PEG capped gold NPs were able to remain in the blood 
circulation for longer, increasing the probability of higher NP accumulation within the solid 
tumour. Investigation of tumour biopsies revealed that after 24 hours, gold NPs were found 
within the tumour tissue, as well as in healthy tissue (such as the liver of patients). In pre-
clinical studies, Libutti et al. found that these particles had a half-life of four months in the 
liver [13]. Other studies using gold NPs also showed accumulation into the liver [14]. 
The cellular fate of gold NP following their administration, their distribution within the 
body and their clearance were not assessed in these clinical trials, since there are limiting 
factors  for  such  an  investigation  in  humans.  Nevertheless,  the  impact  of  NPs  that  are 
deposited in tissue for a relatively long time on the different organ systems, such as the 
circulatory, immune and nervous systems is important and has to be assessed. In particular, 
the nervous system is very likely to be exposed to NPs during NP administration, since its 
spatial distribution within the body is in close proximity to the NP exposure sites (see Figure 
1.2).  
Studies about the interaction of inorganic NPs effect on neurons and the central nervous 
system  (CNS)  are  limited  [14,  15,  16].  Therefore,  there  is  an  increasing  need  for 
understanding the interaction of inorganic NPs and neurons.  
In  this  work,  gold  NPs  were  chosen  as  a  model  system  to  study  the  events  and 
consequences of inorganic NPs-biological system interaction. Gold NPs (spheres and hollow) 
were synthesised, capped with  OEG  (short  PEG)  layer and functionalised with  a neuron 
targeting peptide (Lysine terminated-Tet1). Then neuron-like cell lines (PC12 and SH-SY5Y 
cells)  were  exposed  to  the  fabricated  NPs.  Images  obtained  from  transmission  electron 
microscopy (TEM) were used to study how these NPs interacted with the cells. In addition, Chapter 1. Introduction 
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the gold NP interaction with the neuron-like cells was also investigated by employing a novel 
optical  setup,  which  uses  hyperspectral  darkfield  microscopy  that  was  developed  by  the 
Muskens group (University of Southampton). The analysis of both the NP samples, as well as 
the biological samples, was performed by Mrs Tasha Fairbairn. 
 
Figure 1.2. The human nervous system is in close proximity to the possible sites of inorganic NP 
exposure, including skin, gastrointestinal tract, as well as olfactory, respiratory and circulatory systems. 
1.2  Overview of the Thesis 
This Thesis investigates the interaction of inorganic NPs with neuron-like cells, and uses 
gold NPs as a model to understand how the different type (spherical- and hollow- shaped) of 
NPs, as well as the functionality of particles (OEG ligand or cell specific peptide) influence 
the way they interact with these cells. Chapter 1. Introduction 
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The Thesis comprises of five Chapters. A theoretical background on the nervous system, 
and  the  neuron-like  cell  lines  that  were  chosen  to  investigate  the  scientific  questions  of 
interest,  PC12  and  SH-SY5Y  cells  (which  are  considered  to  be  good  models  for 
neurobiological investigations and share many characteristics with primary neurons), as well 
as on the processes of synthesis of gold NPs employed in the experiments carried out, is 
presented  in  Chapter  2.  The  chapter  finishes  with  a  brief  reference  to  the  hyperspectral 
darkfield imaging. 
Chapter  3  is  concerned  with  the  detailed  experimental  processes  involved  in  the 
preparation of morphologically sophisticated and functional inorganic NPs, as well as the 
development  of  new  protocols  and  techniques  associated  with  their  implementation  in 
biological studies. This chapter also includes a detailed description of the protocols employed 
and refined during neuron-like cell culturing of PC12 and SH-SY5Y cells. In addition, the 
preparation of the biological samples for transmission electron and hyperspectral darkfield 
microscopies is outlined in this chapter.  
Chapter 4 investigates the interaction of the synthesised gold NPs with the neuron-like cell 
lines  by  imaging  them  with  TEM.  The  development  of  gold  NPs  with  extended 
functionalities with respect to biostability, imaging and neuron targeting is also discussed in 
this  chapter.  Moreover,  in  Chapter  4,  a  different  approach  is  presented  for  imaging  the 
synthesised gold NPs on a TEM grid and within biological samples prepared by the author, 
which was conducted through our collaboration with Muskens group. Mrs Tasha Fairbairn 
developed  a  hyperspectral  darkfield  microscopy  setup,  for  imaging  and  spectroscopy  of 
individual hollow gold NPs.  
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2.1  Nervous system: overview of the system and its importance 
Neurons are the major components of the nervous system. These cells are responsible for 
coordinating the actions of the body and for relying information between its different regions 
in the form of electrochemical signals. 
 
Figure 2.1. A typical neuronal cell. 
Neurons are comprised of axonal and somatodendritic regions. These are distinct to each 
other, both spatially as well as functionally. The neuron cell soma is similar to that of a 
typical cell; it has the same subcellular organelles, but is capable of a high rate of protein 
production.  Therefore,  after  proteins  are  synthesised  in  the  cell  soma  they  have  to  be 
transported into and along the axon cytoskeleton by axonal transport. Neurons have a high 
population of mitochondria (energy production organelles) as they have a high metabolic 
demand in order to carry out basic cellular processes, such as axonal transport.  
The neuron’s cellular function is highly dependent of the proper functioning of its axonal 
transport,  consisting  of  a  cytoskeleton  and  associated  transport  machinery,  i.e.  motor 
proteins.  The  neuronal  cytoskeleton  is  made  up  of  long  polarized  proteins  called 
microtubules,  which  have  a  negative  and  a  positive  end.  The  cytoskeletal  nanomatrix  is 
regulated  and  supported  by  a  specialised  family  of  proteins,  the  microtubule-associated 
proteins  (MAP,  MAP2  and  MAPT  or  tau).  The  microtubule  scaffolding  supports  the 
intraneuronal transport system, which is used by molecules and organelles to move along the 
neuron. Their direction of travel is mainly defined by the microtubule polarity and the motor Chapter 2. Theoretical Background 
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protein involved. The axonal region is characterised by a unidirectional polarity, whereas the 
somatodendritic region has a bidirectional polarity [17]. 
2.2  Neuron cell lines 
The neuronal cell lines employed in this work were PC12 cells and SH-SY5Y cells, as 
they are considered to be good models for neurobiological investigations and share many 
characteristics with primary neurons. In the presence of neuron growth factor (NGF), PC12 
pheochromocytoma cells stop dividing, then differentiate into neuron-like cells, and extend 
neurites which are highly branched (see Figures 4.1 and 4.2). Once differentiated, they have 
neuron cell properties (similar to primary sympathetic neurons) and express receptors for 
nicotinic  acetylcholine,  choline  acetyltransferase,  GABA  and  tyrosine  hydroxylase.  PC12 
cells  can  also  produce  and  excrete  dopamine  and  noradrenaline  (neurotransmitters)  [18]. 
They  are considered to  be a  good neurobiological  and neurochemical  model system,  for 
example, in investigations of mechanisms involved in the neurite outgrowth, as well as the 
synthesis and release of neurotransmitters [19, 20].  
SH-SY5Y neuroblastoma cells, in the presence of retinoic acid, are able to differentiate 
into  cells  with  neuron-like  properties.  The  differentiated  SH-SY5Y  cells  possess 
characteristics  of  primary  neuronal  cells,  as  they  express  neuronal  markers,  and  have 
neuronal filaments, neuronal polarity markers (tau and MAP-2 proteins) and GAP-43 protein. 
Also, they are able to respond to neuronal growth factors, such as brain derived neurotrophic 
factor  [21].  The  differentiated  SH-SY5Y  cells  can  serve  as  a  model  for  studying  the 
mechanisms of a damaged axonal transport system, characterised by destabilization of the 
microtubule scaffolding [22]. 
2.3  Physicochemical properties of metallic NPs 
As discussed earlier in Chapter 1, metallic NPs are used in a wide range of applications 
which  are  based  on  their  exceptional  physicochemical  properties.  These  properties  of 
inorganic  NPs  arise  mainly  due  to  their  metallic  component  and  small  size  (10
-9  m), Chapter 2. Theoretical Background 
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compared to the bulk material [1, 2]. In noble metal NPs (such as gold NPs) with a diameter 
smaller  than  the  wavelength  of  light  (λ),  a  unique  optical  phenomenon  is  observed,  the 
localised surface plasmon resonance (SPR) [23, 24]. SPR arises when the NPs are subjected 
to an electromagnetic field at a particular frequency, and as a consequence the metal free 
electrons oscillate collectively and in a resonant frequency with the electromagnetic wave. 
These resonant, collective oscillations have as an effect the enhancement of the absorption 
and  scattering,  extinction,  of  the  electromagnetic  field  in  resonance  with  the  NPs  SPR 
frequency, from which the unique optical properties of noble metal NPs arise. 
 
Figure 2.2. An illustration of the plasmon oscillation of metallic spherical NPs. The electron charge (e-) cloud 
is displaced relative to the nucleus [23]. 
Some of the factors which control the SPR, include the size and shape of the NPs, and 
electric properties of the medium that the NPs are embedded; as suggested by the Mie theory 
[23, 24]. 
According to Mie theory, when the radius of the NPs, R, is much smaller than λ, then the 
extinction cross-section can be expressed as below, 
                   Equation (2.1) 
where εm is the dielectric constant of the embedded medium, and ε’(λ) + iε” (λ) is the NPs 
dielectric function. Furthermore, the NPs (spheres) maximum extinction takes place, at λ, as 
an individual plasmon band, whereby ε’ = - 2εm. On the other hand, the SPR of NPs with a 
different shape, like hollow, can be obtained by other mathematical methods, for example 
discrete-dipole  approximation  of  Mie’s  theory  [25,  26].  Moreover,  by  employing  the Chapter 2. Theoretical Background 
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discrete-dipole approximation of Mie’s theory, it is shown that the SPR of the hollow gold 
NPs depends on the radius of the NPs as well as the thickness of the NPs shell. 
As mention earlier in this section, the LSPR of gold NPs depends on the NPs size, thus by 
tuning the size of gold NPs their LSPR can also be controlled. For example, spherical gold 
NPs with a small diameter (20nm), absorb the light (almost) completely, with insignificant 
scattering. As their size increases the contribution of the absorption component to the overall 
excitation spectra decreases, whereas the contribution of scattering increases [24]. Therefore, 
NPs of the appropriate size can be used, accordingly, in the most suitable optical imaging 
applications. Such an example, are large NPs (like hollow gold NPs) which can be employed 
in light-scattering imaging setups. 
2.4  Synthesis of inorganic nanoparticles 
Gold hollow (Section 2.4.1) and spherical (Section 2.4.2) NPs were synthesised by wet 
chemistry  processes.  The  theoretical  background  of  these  synthetic  processes  will  be 
described below. 
2.4.1  Hollow gold nanoparticles 
The  preparation  of  hollow  gold  NPs  involved  the  synthesis  of  spherical  silver  NPs, 
followed  by  a  galvanic  replacement  reaction,  during  which  the  gold  ions  (AuCl
-
4)  were 
reduced into Au
0, whereas silver was oxidised to Ag
+ ions (Equation 2.2). A single gold atom 
replaced three silver atoms resulting to the formation of hollow gold nanoparticles (Scheme 
I) [27].  
3Ag (s) + AuCl
- 4 (aq)               Au (s) + 3Ag 
+ (aq) + 4Cl
- (aq) 
Equation (2.2) Chapter 2. Theoretical Background 
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Scheme I 
2.4.2  Spherical gold nanoparticles 
The  spherical  gold  NPs  were  synthesised  by  the  well-established  Turkevish  method, 
whereby Au
3+ is reduced by trisodium citrate [28]. 
 
Figure 2.3. Scheme showing the different steps involved in the formation of spherical gold NPs: A. oxidation of 
trisodium citrate, B. reduction of AuCl3, and C. disproportionation of AuCl [28]. 
In [28] is suggested that three steps, illustrated in Figure 2.3, take place in series and 
parallel,  during  the  spherical  gold  NP  synthesis.  Firstly,  oxidation  of  citrate  anions,  by 
oxygen in air, takes place, and as a result dicarboxy acetone is formed. Furthermore, Au
3+ 
ions are reduced to Au
+ cations. The dicarboxy acetone forms complexes with Au
+ cations 
(three Au
+ cations bind to a minimum of two dicarboxy acetone moieties). The dicarboxy 
acetone plays a key role in nucleation. Also, the Au
+ cations disproportionate to Au
0, which 
then adsorb to Au
+ cations, and as a result large complexes are formed. Finally, nucleation 
takes place when these large complexes reach a critical size of 2 nm (according to [28]). 
Then the nuclei formed grow into NPs, as the Au
0 (in the solution) are absorbed by the 
nuclei. The trisodium citrate present in the solution, provides stability to the growing NPs. Chapter 2. Theoretical Background 
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2.5  Surface capping and functionalisation of the nanoparticles  
2.5.1  Oligoethylene glycol capping of gold nanoparticles 
NPs were coated with the OEG ligand via its –HS group. 
 
Figure 2.4. The chemical structure of the OEG ligand (SH-OEG-COOH). 
The OEG-capping provides stability to the gold NPs when they enter an environment high 
in salt and proteins, which is considered to be very challenging for the NPs to stay in a 
colloidal form. According to [29], this is achieved via the hydrophilic (-(EG)6-OCH2-COOH) 
part and the hydrophobic (C11) carbon chain of the ligand, which gives the NPs, solubility 
and stability, respectively. Furthermore, the (-(EG)6-OCH2-COOH) unit of the ligand, also 
allows further modification of the NPs surface by ligands containing amine, such as peptides. 
2.5.2  Peptide functionalisation of gold nanoparticles 
The  peptide  functionalization  involves  a  straightforward  coupling  method,  whereby 
carboxyl groups couple to primary amine groups, in the presence of a zero-length cross-
linker, 1-(3-(dimethylamino)propyl)-3-ethyl-carbodiimidemethiodide (EDC) [30].  
Firstly, a reaction between EDC with a carboxylic group takes place which results in the 
production of O-acylisourea. O-acylisourea is an amine reactive intermediate which i. Reacts 
with an amine or ii. Hydrolyses to generate a carboxyl. In an order to avoid the latter, N-
hydroxysulfosuccinimide (sulfo-NHS) is employed, so as to rise the reaction’s efficiency. 
That is by stabilising O-acylisourea, as it converts it to  sulfo-NHS ester which is amine 
reactive [30]. 
A  neuron  targeting  ligand,  lysine  terminated-Tet1  peptide  (peptide  sequence: 
KHLNILSTLWKYR), was chosen to induce the delivery of gold NPs into the cells, as it can 
mediate a specific as well as an enhanced binding of nanostructures (such as polymersomes Chapter 2. Theoretical Background 
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[31]) or non-viral vectors, on differentiated PC12 cells, differentiated SH-SY5Y cells, dorsal 
ganglion neurons  and primary motor neurons [32, 33, 34]. The membrane of these cells 
expresses an acidic glycolipid, GTb1 ganglioside, which acts as a receptor for Tet1 [35]. This 
neuron-targeting peptide it has similar binding characteristics to that of tetanus toxin [34], 
and enables functionalised nanostructures to enter the cells by first binding onto the cellular 
surface and then undergo retrograde transport from the neurites to the cell soma [32].  
In Section 3.2.2, a detailed protocol of Tet1 peptide functionalization of the gold NPs is 
presented. 
2.6  Hyperspectral darkfield microscopy 
Over  the  last  few  years,  a  great  effort  has  been  put  in  developing  advanced  imaging 
techniques  for  producing  images  of  single  non-fluorescent  inorganic  metallic  NPs
  [36], 
which could extend and complement the knowledge in the biomedical science field currently 
obtained from other microscopic techniques (such as fluorescence microscopy).  
A powerful technique for imaging and spectroscopy of inorganic metallic NPs (diameter > 
20 nm), detects the light that is elastically scattered by these particles and is called darkfield 
microscopy [37, 38]. Furthermore, darkfield spectroscopy (together with the metallic NPs 
SPR’s  high  sensitivity  to  small  alterations  in  the  local  environment)  has  been  broadly 
employed for sensing [39]. A broadband single NP spectroscopy results in fast and/or high 
resolution of a single NP, but it has a few drawbacks in the context of biological imaging 
studies. This is because the metallic NPs which interact with a biological sample are heated 
up from the broad spectrum of irradiation [40, 10].  
 In the hyperspectral darkfield microscopy setup developed by Muskens group, a spectral 
imaging of a large area with fast integration times has been made possible by a combination 
of  a  standard  darkfield  microscopy  setup  with  a  spectrally  filtered  source.  This  setup  is 
presented in detail in [41], and as mentioned earlier, in Chapter 4 its application in carrying 
out spectral measurements of hollow gold NPs and of biological samples, synthesised and 
prepared, respectively, by the author.   
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3.1  Synthesis of inorganic nanoparticles 
3.1.1  Hollow gold nanoparticles 
Hollow  gold  NPs  were  prepared  using  spherical  silver  NPs  as  templates,  followed  by  a 
galvanic replacement reaction. The silver template growth solution was prepared by stirring 
CTAB (0.2 M, 80 ml), silver nitrate (0.05 M, 400 μl) and L-ascorbic acid (0.1 M, 2 ml) at   
35 °C. It is important to note that the L-ascorbic acid solution has to be prepared just before 
the process of synthesis. Since L-ascorbic acid oxidises readily when it is exposed in air and 
light [42].  
Firstly, silver NPs were synthesised (as seeds), separately, by silver nitrate (2.5 mM, 1 ml) 
reduction in the presence of trisodium citrate (2.5 mM, 1 ml), Milli-Q water (8 ml) and ice-
cold sodium borohydride (0.001 M, 25 μl). These silver seeds (400 μl) were then injected to 
the reaction mixture, followed by addition of sodium hydroxide solution (1 M, 2 ml). A 
colour transition was observed from colourless to orange−yellow, signifying the formation of 
silver NPs. The reaction was completed after 24 hours, and the final product was purified 
from excess CTAB, by one centrifugation-decantation step (2500 rcf, 15 minutes) and re-
dispersed in Milli-Q water (40 ml).  
The hollow NPs were formed by a slow, constant addition of sodium tetrachloroaurate 
(III) dihydrate aqueous solution (1 mM, 0.25 ml) to a silver template solution (10 ml), which 
was  heated  to  reflux.  There  was  a  colour  transition  from  orange−yellow  to  deep  blue, 
indicating the formation of hollow gold NPs. The NP solution was left to cool down to room 
temperature and was stored at 4 
oC. 
3.1.2  Spherical gold nanoparticles 
Spherical gold NPs were synthesised by the citrate reduction method. A trisodium citrate 
solution  (2.5  ml,  19.5  mM)  was  mixed  with  a  sodium  tetrachloroaurate  (III)  dihydrate 
solution (0.5 mM, 25 ml), at boiling temperatures and under vigorous stirring, leading to the 
formation of spherical NPs. There was a colour change from pale yellow to wine red. Once 
the reaction mixture was cooled to room temperature, it was then purified by filtration (0.45 Chapter 3. Methods and Techniques  17 
μm filter, Millipore). The citrate gold NPs (27.5 ml) were then electrostatically stabilised 
with bis(p-sulfonatophenyl)-phenyl  phosphine  dehydrate dipotassium salt (10 mg) capping 
ligand. After two hours of stirring at room temperature, the NPs were precipitated by the 
addition of sodium chloride (50 mg) and purified by one step of centrifugation-decantation 
(2500 rcf, 5 minutes). The NPs were redispersed in Milli-Q water. 
3.2  Surface capping and functionalisation of the nanoparticles 
3.2.1  Oligoethylene glycol capping of gold nanoparticles 
A  short  polyethylene  glycol  (PEG)  ligand,  oligoethylene  glycol  (OEG),  was  used  to 
functionalize the outer surface of gold NPs, so that they would stay in a colloidal form when 
they enter the cell media. This means the NPs do not precipitate out, but they disperse nicely 
in the media. A fresh OEG-COOH solution (5 mg/ml, 200 μl) was prepared and injected into 
a colloidal solution of (i) spherical gold NPs (5 nM, 10 ml) while stirring and was left to 
react for two hours at room temperature, or (ii) hollow gold NPs (0.5 Optical Density, O.D., 
5 ml) while sonicating at 4 
oC for one hour. The reaction mixture was kept overnight at 4 
oC 
and then purified from the excess ligand by three purification steps (8000 rcf, 15 minutes per 
step). NPs were re-dispersed in sodium borate buffer (0.1 M, pH 9).  
3.2.2  Peptide functionalisation of gold nanoparticles  
A  neuron  targeting  peptide,  lysine  terminated-Tet1  (peptide  sequence: 
KHLNILSTLWKYR) was conjugated to the OEG-capped gold NPs in the presence of EDC 
and s-NHS coupling agents. Namely, the peptide (100 μl, 0.15 mM; 0.1 M sodium borate 
buffer, pH 9) was added to 5 ml of gold NPs (0.3 O.D.; 0.1 M sodium borate buffer, pH 9), 
followed by the addition of EDC (50 μl, 0.2 M) and sulfo-NHS (100 μl, 0.2 M), and shaken 
gently overnight at room temperature. The peptide functionalised-NPs were purified from 
excess  peptide  ligands  and  coupling  reagents  by  three  purification  steps  (13,400  rcf,  15 
minutes per step), and re-dispersed in 100 μl of cell growth media. Chapter 3. Methods and Techniques  18 
3.3  Characterisation techniques of inorganic nanoparticles 
The  NPs  were  characterised  with  UV-Visible  spectra  and  transmission  electron 
microscopy (TEM). The UV – Visible spectra of the colloidal NPs were obtained using Cary 
100 UV-Vis spectrophotometer, in the range of 450 to 800 nm. TEM images were taken with 
a Hitachi H7000 transmission electron microscope operating at a bias voltage of 100 kV. The 
TEM specimen preparation involved deposition and evaporation of a drop of the NP solution 
on  a  grid  (carbon-copper  coated  400  mesh).  The  average  size  distribution  of  NPs  was 
determined  by  analysing  the  TEM  images  of  the  NPs,  and  the  data  was  presented  in 
histograms (see Chapter 4).  
3.4  Cell culture 
The chemicals used in cell culturing processes, described in this section, were purchased 
from Sigma Aldrich, and culture media and components were purchased from Invitrogen-
Gibco. 
3.4.1  PC12 cell culturing 
PC12 cells were maintained in RPMI (Roswell Park Memorial Institute) cell media which 
was supplemented with penicillin/streptomycin, 7 % horse serum (HS), 7 % heat-deactivated 
fetal bovine serum (FBS), and D-glucose in a humidified atmosphere of 5 % CO2 and 95 % 
air at 37 °C. For the experiments, cells were seeded in a 24-well plate on glass coverslips 
(pre-coated with poly-D-lysine), at a density of 2 x 10
4 cells per well. The following day, 
cells were differentiated by exchanging their media from rich to low serum media (1 % of 
HS, 1 % of FBS), supplemented with 5 μl of neuron growth factor (NGF, 50 ng/ml). PC12 
cells required seven days to fully extent their neurites.  
3.4.2  SH-SY5Y cell culturing 
SH-SY5Y  cells  were  maintained  in  F-12  cell  media,  which  was  supplemented  with 
penicillin/streptomycin, non-essential amino acids and 5 % FBS, in a humidified atmosphere Chapter 3. Methods and Techniques  19 
of 5 % CO2 and 95 % air at 37 °C. They were seeded in a 12-well plate on glass coverslips, at 
a density of 2 x 10
4 cells per well, in 1 ml supplemented cell media. The following day, cells 
were differentiated by the addition of retinoic acid (1 μl, 3 μg/ml). 
3.5  Exposure of inorganic nanoparticles to neurons 
3.5.1  Preparation of biological samples for transmission electron microscopy 
imaging 
In the first experiment (see Section 4.3) the PC12 cells were incubated with OEG capped 
spherical (5 nM) or hollow (1 O.D.) gold NPs, for six hours. In the second experiment, PC12 
cells  were  incubated  with  OEG-capped  or  lysine  terminatedTet1-functionalised  spherical 
gold NPs (5 nM), for one hour.  
The samples were then washed three times with pre-warmed (at 37 °C) phosphate buffer 
saline  (PBS)  pH  7.4,  then  incubated  for  20  minutes  with  the  fixative,  2  % 
paraformaldehyde/1.5 % glutaraldehyde in RPMI media containing HEPES buffer (20 mM, 
pH 7.4), which had been also pre-warmed at 37 °C. The cells were then washed twice in 0.1 
M sodium cacodylate (pH 7.2―7.4). Sodium cacodylate was removed, and osmium mixture 
(1.5 % of potassium ferricyanide mixed with 1% of osmium) was added to the cells for one 
hour  at  4 
oC.  The  samples  were  washed  several  times  in  0.1  M  sodium  cacodylate  and 
dehydrated stepwise in ethanol; in each step the samples were incubated with ethanol, twice, 
for five minutes (30 % ethanol, 50 % ethanol, acetate uranyl in 70 % ethanol, incubated for 
40 minutes, then in 70 % ethanol, 95% ethanol and finally in absolute alcohol twice for 15 
minutes). Samples were then incubated in a 50:50 mixture of acetonitrile and TAAB© resin 
(overnight), followed by an exchange into neat TAAB resin for six hours. The cover slips 
were then removed from the resin, and mounted onto capsules of previously polymerised 
resin. These were then polymerised overnight, at 65
oC. The cover slips were detached from 
the  capsules  by  freezing  them  in  liquid  nitrogen  and  breaking  them  off.  The  samples 
embedded in resin were then sectioned using a microtome. Lead citrate was used for post 
embedding staining of sections on a TEM grid. A drop of lead citrate was put on parafilm in 
a  petri  dish  that  had  sodium  hydroxide  pellets  in  it.  The  sodium  hydroxide  acted Chapter 3. Methods and Techniques  20 
hydroscopicaly to prevent precipitation of lead carbonate. The grid was then inverted on the 
drop, covered with a lid and left for five minutes. The grid was then washed quickly with 
distilled water and the excess water was blotted off. Samples were then imaged with the 
transmission electron microscope. 
3.5.2  Preparation of biological samples for hyperspectral darkfield imaging 
SH-SY5Y cells were incubated with hollow gold peptide-functionalised NPs for one hour 
(1 O.D.), and then washed three times with PBS, pH 7.4. The samples were fixed by 15 
minute incubation with 4 % paraformaldehyde. All reagents were pre-warmed at 37 
◦C, to 
achieve good fixation of the samples. The fixative was then removed by washing the samples 
three times with PBS, followed by water. The glass coverslips were washed again with plenty 
Milli-Q  water  (excess  water  was  blotted  off)  and  then  mounted  with  4’,  6-diamidino-2-
phenylindole (DAPI, a fluorescent dye which stains the cell nuclei) mounting media onto a 
glass microscope slide. 
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4.1  Neuron cell lines 
4.1.1  Neuron–like PC12 cell line 
The PC12 cells were seeded carefully, so that they would spread evenly, and adhere nicely, 
on the glass coverslip. This was very important for the cells to form nice connections with 
each other (see figure below). The number of the cells seeded was also important, as a high 
number of cells would lead to the formation of clumps resulting in the death of the cells at 
the base of the clump. Moreover, if cells were in small numbers they would not be able to 
form connections with each other, and again they would not survive. Therefore, the seeding 
method prior to differentiation was very important. 
50um
 
Figure 4.1. Fluorescence images of differentiated PC12 cells (at day 5 of differentiation); green βIII-tubulin 
staining counter-stained with DAPI, blue. Chapter 4. Interaction of gold NPs with neurons  23 
 
Figure 4.2. Brightfield image of differentiated PC12 cells. Scale bar = 20μm. 
After the cells were seeded, they were given enough time to adhere (24 hours), before they 
were induced to differentiate, and start projecting out neurites. Undifferentiated PC12 cells 
are not able to differentiate if they do not adhere properly on a substrate [43]. For PC12 cells 
to  fully  form  an  extensive  network  with  each  other,  so  that  they  could  be  used  in  the 
experiments with NPs, they were left for a week in the presence of NGF and low serum 
media. These cells were very delicate, hence extensive handling could easily induce their 
death.  On  the  other  hand,  SH-SY5Y  cells  were  much  easier  to  handle  and  used  in 
experiments, compared to PC12 cells. 
4.1.2   Neuron–like SH-SY5Y cell line 
The SH-SY5Y cells is another neuron-like cell line, which is considered easier to handle 
than PC12 cells. They  can adhere to surfaces  and proliferate over time better and faster 
compared to other neuron cell lines. SH-SY5Y cells were left to adhere onto the seeding 
surface overnight and were then induced to differentiate in the presence of retinoic acid. A 
nice well networked cell culture was ready after four days of differentiation (see Figure 4.3). Chapter 4. Interaction of gold NPs with neurons  24 
 
Figure 4.3. A. Fluorescence image of differentiated SHSY-5Y cells, B. An overlay of a brightfield image with 
fluorescence image of differentiated SH-SY5Y cells.  
4.2  Gold nanoparticles 
4.2.1  Spherical gold NPs 
The gold  spherical  NPs synthesised by the Turkevich method  (see Section 2.3.2)  and 
stabilised by the ligand exchange reaction had an average diameter of 15 nm (Figure 4.4). 
The sharp LSPR peak at 520 nm indicated the monodispersity of the synthesised gold NPs, as 
well as that were stable and did not form any aggregates. 
 
Figure 4.4. TEM image of spherical gold nanoparticles. Scale bar = 100 nm. Chapter 4. Interaction of gold NPs with neurons  25 
 
Figure 4.5. A. UV-vis spectrum of spherical gold nanoparticles and B. a histogram of the size distribution of 
spherical gold nanoparticles. 
4.2.2  Hollow gold NPs 
The  preparation  of  hollow  gold  NPs  involved  the  synthesis  of  spherical  silver  NPs, 
followed by a galvanic replacement reaction. The hollow gold NPs prepared by the galvanic 
replacement reaction had an almost rounded shape (Figure 4.6.), with an average size of 70 
nm and a SPR peak at 700 nm. 
 
Figure 4.6. TEM image of hollow gold nanoparticles. Scale bar = 50 nm. Chapter 4. Interaction of gold NPs with neurons  26 
 
Figure 4.7. A.UV-visible spectra, and B. size distribution of the hollow gold NPs. 
The TEM images and the size distribution of spherical gold and hollow gold NPs showed 
evidence of good NP monodispersity. 
Looking Figure 4.5A and Figure 4.7A, it can be observed that the LSPR peaks of gold 
spheres and hollow NPs are different. These optical spectra are characteristic for each type of 
gold NP, as (in general) each type of noble metal NP has a unique optical signature which 
enables scientists to employ a particular NP to the application of interest [44, 45] (see Section 
2.3). For example, in photothermal cancer therapy hollow gold NPs (instead of other type of 
NPs) have been employed as heat transfer agents, as their LSPR is close to the near-infrared 
region (and could be shifted even more towards that region by increasing their size) [26]. 
4.2.1  Peptide functionalisation of gold nanoparticles  
As mentioned in Chapter 3, the gold NPs were capped with the OEG ligand, and then 
were functionalised with the neuron targeting peptide, lysine terminated-Tet1. The figure 
below is a schematic of the different stages of NP capping and functionalization, with the 
OEG and Tet1, respectively. 
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Figure 4.8. OEG capping followed by peptide functionalisation of gold NPs. 
The OEG-capped NPs did not aggregate when they entered an environment that was high 
in salt and proteins (such as the cell media). This is because the OEG-capping provided 
stability to the NPs, via the hydrophilic (-(EG)6-OCH2-COOH) part and the hydrophobic 
(C11)  carbon  chain  of  the  ligand  [29],  which  gave  the  NPs,  solubility  and  stability, 
respectively (see Figure 2.4 for the chemical structure of the OEG ligand). Furthermore, the 
(-(EG)6-OCH2-COOH) unit of the ligand, also provided the NPs with functional carboxylic 
groups. 
The peptide functionalization of the NPs, as illustrated in Figure 4.9, resulted in a red shift 
in the LSPR of gold NPs. This could be attributed to a change in the refractive index, as a 
consequence of the new layer formed by the addition of the peptide ligand around the NPs 
[46]. In addition, the sharp LSPR peak of the peptide functionalised NPs suggested that the 
NPs did not aggregate, which was consistent with the TEM image (shown in Figure 4.9). 
 
Figure 4.9. UV-visible spectra of the OEG-capped NPs (red line) and the Tet1-OEG capped NPs (green line), 
and TEM image of the Tet1-OEG coated NPs (scale bar = 200 nm). 
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Moreover, the hollow gold NPs did not precipitate out during the functionalization process 
with the peptide, too. They stayed in a colloidal form, which can be confirmed by the TEM 
images  and  the  UV-visible  spectra  of  the  particles  (see  Figure  4.10).  A  red-shift  was 
observed when the UV-visible spectra of the peptide functionalised NPs were plotted. 
 
Figure 4.10. a. The UV-visible spectra of the hollow OEG-capped NPs (black line) and b. the hollow Tet1-
OEG capped NPs (red line), and TEM image of the hollow Tet1-OEG coated NPs (scale bar = 200 nm). 
The Tet1 peptide is slightly hydrophobic, as it is illustrated by the hydropathy plot in 
Figure 4.11. Therefore its attachment on gold NPs was tricky, as the reaction had to reach 
completion  without  the  NPs  precipitating  out  from  the  solution,  and  hence  the  ideal 
conditions of attachment described in Section 3.2.2, had to be found.  
  
Figure 4.11. Hydropathy plot of lysine terminated-Tet1 peptide; blue= basic, green= polar, grey= aliphatic, 
light green= aromatic. Chapter 4. Interaction of gold NPs with neurons  29 
4.3  Cellular fate of gold nanoparticles in PC12 cells 
The motivation for the work presented in this Thesis, as described in Chapter 1, was to 
investigate the interaction of inorganic NPs (more specifically gold), with neuron cells, in an 
attempt to gain more knowledge regarding the NP-cell interface, as a result of our exposure 
to NPs in our daily life [9]. This study involved the exposure of neuron-like cells to gold 
NPs, that were either OEG-capped or peptide-functionalised, and to investigate the fate of the 
NPs  within  the  cells  by  using  imaging  techniques,  such  as  transmission  electron  and 
hyperspectral darkfield microscopy. 
Differentiated PC12 cells were incubated with spherical and hollow gold NPs capped with 
OEG, in order to assess the uptake and fate of gold NPs within the cells. A firm OEG coating 
surrounded these gold NPs (see Figure 4.8), to ensure their biostability in cell serum media 
that  were  rich  in  protein  and  salts  [47].  This  surface  capping  of  gold  NP  makes  them 
biocompatible, because the cell and its components are not exposed directly to the highly 
catalytic metallic surface of the gold NPs. These OEG capped NPs were expected to enter the 
cell in low numbers, compared to NPs that were functionalised with a cell targeting ligand
 
[47, 10]. In this work, the experimental findings regarding the cell interaction and uptake of 
NPs, was drawn based on the qualitative data obtained from TEM images. Therefore, to 
validate these findings and construct a complete picture, further experiments are needed, and 
as  due  to  time  constrains  these  were  not  possible  in  the  current  project.  The  actual 
concentrations of gold NPs within cells could be quantified with accuracy by a standard 
technique, the inductively coupled plasma-mass spectrometry (ICP-MS). The gold NPs were 
easily identified within a cell using a transmission electron microscope, due to their dense 
electron contrast (see Figure 4.12). TEM images revealed that spheres and hollow gold NPs 
were found within the cell, indicating that some of them were able to traverse through the 
cell membrane. Moreover, it was observed that hollow gold NPs seemed to be able to enter 
the cell in relatively lower amounts, compared to spherical NPs. This could be attributed to 
their size difference, as hollow gold NPs were much bigger (70 nm) than the spherical (15 
nm) gold NPs.  Chapter 4. Interaction of gold NPs with neurons  30 
 
Figure 4.12. TEM images of PC12 cells incubated with spherical (A) and hollow (B) gold nanoparticles. Insert: 
an enlarged image of a hollow gold NP marked by the asterisk; White arrows: point out the gold nanoparticles, 
black arrows: show the membrane of the cell. 
The  NP  size  and  surface  chemistry  determine  the  way  NPs  interact  with  the  cellular 
membrane, hence the pathway involved in their uptake. The pathway and mechanism of NP 
entry could be by macropinocytosis, receptor mediated endocytosis (clathrin- or caveolae-
mediated), clathrin- or caveolae-independent, as well as directly via passive diffusion. It has 
been  suggested  that  the  major  mechanism  of  uptake  involved  is  the  receptor  mediated 
endocytosis [8], though it has to be noted that this is highly dependent on the experimental 
conditions employed in a particular study, including the type of cells involved. The rate and 
extent of NP endocytosis depend on the size of the NP, as well as on the type of the cell.  
As mentioned earlier,  ICP-MS measurements  of the amount of gold  found within the 
neuron-like  cells  would  enable  us  to  draw  solid  conclusions  by  making  quantitative 
comparisons between these two different gold NPs. In addition, critical evaluation of the 
information found can be done with the data currently found in literature by other research 
groups. For example, in [7] it was suggested that the free energy during NP endocytosis 
required for NP interaction with the membrane receptors, (and for the recruitment of these 
receptors on the site enclosing the NPs) was considered to be more in bigger NPs (74 nm) 
than smaller ones (14 nm and 50 nm). Also, in a different type of cell (human umbilical vein Chapter 4. Interaction of gold NPs with neurons  31 
endothelial cells) spherical gold NPs (15 nm) were found at higher concentrations within 
cells compared to hollow gold (100 nm) [10].  
Furthermore,  other  cellular  processes  involved  in  NP  endocytosis  or  even  exocytosis, 
could not be specifically defined at this stage. Further investigations are needed in order to 
identify the exact cellular pathway involved, for example by assessing the NP uptake by 
blocking specific pathways. This information will enable us to construct a complete picture 
regarding the NP uptake and intracellular distribution of gold NPs within a neuron cell. 
4.4  Cellular fate of Tet1-functionalised gold nanoparticles in PC12 cells 
Another part of the investigation about gold NP-neuron interaction, involved the exposure 
of  differentiated  PC12  cells  to  NPs  tagged  with  lysine  terminated-Tet1  neuron  specific 
targeting peptide. It was hypothesised that peptide-functionalised NPs would readily enter the 
cell; henceforth the fate of a large amount of NPs would be observed, however without 
triggering any signalling pathways [34, 48]. In an in vitro system there are time limitations 
for  carrying  out  an  experiment,  hence  peptide  functionalised  NPs  were  designed  in  an 
attempt to ‘model’ the exposure of cells to a large amount of NPs, as a consequence of a 
constant long term exposure to these NPs.  
As  mentioned  previously,  the  surface  chemistry  of  the  NPs  determines  the  way  NPs 
interact with the membrane of the cell, thus the pathway involved in their uptake. In the case 
of the peptide-functionalised NPs, the Tet1 peptide has a high affinity and specifically binds 
to the Gtb1 (trisialoganglioside clostridial toxin) receptors, which are readily expressed on 
the membranes of these neuron-like cells [49]. An illustration of a lysine terminated Tet1-
functionalised NP interacting with Gtb1 on the cell surface membrane is shown in the figure 
below. Hence, it is suggested that the majority of the Tet1 functionalised NPs would have 
entered the cell via the Gtb1 receptor-mediated pathway [49].  Chapter 4. Interaction of gold NPs with neurons  32 
 
Figure 4.13. Interaction of Tet1 functionalised NP with the cell surface membrane. 
  
Figure 4.14. TEM images of PC12 neuron-like cells treated with OEG capped NPs. Scale bar = 200 nm Chapter 4. Interaction of gold NPs with neurons  33 
 
Figure 4.15. TEM images of PC12 neuron cell line that were treated with Tet1-functionalised NPs. Scale bars = 
200 nm.  
Differentiated PC12 neurons were incubated for one hour with spherical gold NPs. OEG-
capped  particles  were  taken  up  by  the  neuron-like  cells  non-specifically,  and  they  were 
located in the cytoplasm of cells (see Section 4.3). On the other hand, Tet1-functionalised 
NPs seemed to be taken up more readily by cells. Nevertheless, ICP-MS measurements are 
required in order to validate and confirm these qualitative observations. 
A close observation of the TEM images, in Figure 4.15, reveals something interesting, that 
the internalized Tet1-functionalized gold NPs seemed to be found in small groups trapped 
within sub-cellular organelles. It can be suggested that the cell actively collected these NPs 
into these organelles, after they have entered the cells.  
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Comparing the images of OEG-capped NPs and lysine terminatedTet1-functionalised NPs 
it can be inferred that these loaded vesicles were transported to the inner part of the cell 
around the cell soma particularly close to the perinuclear region (the area around the cell 
nucleus). In [50] a similar observation was noted, when vesicles containing peptide (Tat)-
functionalised Quantum Dots (in HeLa cells) followed a similar path, from the periphery of 
the cell to its perinuclear region via an active transport cellular process. Furthermore, this 
observation was also consistent with previous studies with PC12 cells [35], as well as GI-1 
glioma cells [51]. Nevertheless, further experiments have to be conducted to shed more light 
in the gold NP- neuron cell interaction (particularly about the events taking place within the 
cell following the NP uptake) in order to make solid and constructive comparisons with other 
studies like the ones mentioned above. 
The diffusion of such large vesicles through the crowded and dense cytoplasm is minimal, 
therefore it is suggested that this limitation was overcomed by a retrograde transport system 
involving the hijacking  of the  cellular machinery  (such the microtubule network, dynein 
motor protein, etc.) [34, 50]. As it was mentioned in Chapter 2, Tet1 peptide has similar 
binding characteristics to that of tetanus toxin. Tetanus toxin has the ability to bind to the 
neurons in the periphery and by retrograde transport is transported to the motor neurons [34]. 
Similarly, it was suggested that the Tet1 peptide enabled the peptide functionalised NPs to be 
actively transported to the perinuclear region of the cell.  
Moreover,  a  close  observation  of  the  PC12  cells  following  exposure  to  the  peptide-
functionalised  NPs  under  the  light  microscope  (before  they  were  processed  for  TEM), 
revealed that there was not any significant change in the phenotype of the cells. However, in 
order to study any changes in the functional processes of the cell as a consequence of the 
presence of NPs within the cell both in low (OEG-capped NPs) or high numbers (lysine 
terminated Tet1-functionalised NPs), further investigations are required involving detection 
of proteins that their expression is altered during a stress response by western-blot analysis. Chapter 4. Interaction of gold NPs with neurons  35 
4.5  Hyperspectral  darkfield  imaging  of  single  hollow  gold  NPs  for 
biomedical applications 
Another study with neuron-like cells was carried out whereby individual hollow gold NPs 
were  imaged  within  a  biological  sample,  as  a  part  of  the  investigation  regarding  the 
interaction of inorganic NPs with cells. The study involved differentiated SH-SY5Y cells that 
were exposed to hollow gold Tet1-functionalised NPs. The development of this technique by 
the Muskens group is very important, as hyperspectral darkfield imaging can be extended to 
live cell studies. For example, for studying NP cellular uptake and fate, in which currently 
phototoxicity is considered to be a limiting factor. Such studies will provide us with new 
insight  information  regarding  the  uptake  and  handling  of  NPs  by  the  cell,  as  well  as 
employing single NPs as spectral sensors of a particular sub-cellular activity. 
 
Figure 4.16. Hyperspectral measurements of hollow gold nanoparticles. Image taken from [41] 
The TEM images of OEG-capped hollow gold NPs (on marked TEM grids), such as in 
Figure 4.16 A i-iii, were correlated with the images taken with the hyperspectral darkfield 
setup with incident light wavelength of 713 nm (Figure 4.16iv) in order to detect individual Chapter 4. Interaction of gold NPs with neurons  36 
NPs. Looking at the images in Figure 4.16, it can be observed that there are individual NPs 
(m, k), dimmers (g, n), trimmers (l, i) and the rest NPs on the grid are in clusters. The details 
of the setup parameters can be found in [41]. 
The resonance of m, single hollow gold NP, at 685 nm ±10 nm is in agreement with that 
of hollow gold [52] in other imaging studies with single NPs. The spectral response (red line) 
was qualitatively reproduced, using a numerical model for a single hollow gold NP. The 
TEM image was used to calculate the NP diameter, and the shell thickness was optimized to 
achieve agreement with the spectral resonance position. This is because the shell thickness 
varied amongst the NPs. Furthermore, the morphology of most NPs deviates from that of a 
perfect sphere, which makes the quantitative analysis of the spectral response even more 
complicated.  
In Figure 4.16 C, the mode profile which corresponds to the spectral resonance peak of 
NP m is presented. The resonance could be due to the NPs dipolar mode, with a local field 
enhancement of one order of magnitude. On the other hand, NP k response was not as strong 
as NP m. This discrepancy arises from the difference in the NPs sizes. The scattering cross-
section scales with the square of the particle volume in small NPs, hence even a slight size 
difference could have as a consequence a large difference in the intensity detected. The setup 
by Muskens group is sensitive enough to detect individual NPs smaller than 50 nm, with 
quite short integration time and good signal/noise ratio. 
In comparison to the individual NPs, when the NPs are in groups of two or three (such as 
in n, i and l clusters), a red shift in the spectral response was observed, as expected for 
strongly interacting nanoshells [53]. In particular, the NP cluster i showed a complex spectral 
response with multiple resonances, which could be attributed to the discrepancy in the NP 
size. The theoretical spectrum (in Figure 4.16 B) for the NP cluster g resulted from modelling 
the two NPs. 
4.5.1  Hyperspectral  darkfield  measurements  of  hollow  gold  nanoparticles 
interacting with SH-SY5Y cells 
In  the  previous  sections  of  Chapter  4,  an  investigation  using  transmission  electron 
microscopy  for  studying  NP-cell  interaction  was  presented,  however  this  technique  is Chapter 4. Interaction of gold NPs with neurons  37 
considered  costly  and  time  consuming  compared  to  other  imaging  techniques,  such  as 
hyperspectral darkfield microscopy. Furthermore, the optical properties of gold NPs enable 
the study of single NPs when using the latter technique. 
The  hyperspectral  darkfield  microscope  designed  by  Ms  Tasha  Fairbairn  was  used  to 
study the interaction of single hollow gold NPs with SH-SY5Y cells. SH-SY5Y cells were 
exposed,  for  one  hour,  to  hollow  gold  NPs  functionalised  with  lysine  terminated-Tet1 
peptide. The images of cells obtained using brightfield, DAPI fluorescence and hyperspectral 
darkfield scattering (at 713 nm) microscopy, were overlayed. This was done in an attempt to 
study how the NPs interacted with the cells (see Figure 4.15). In the spatial map, there is a 
clear contribution of darkfield intensity, which is associated with the position of the cell. 
Looking at Figure 4.16 it can be observed that four single bright spot areas were chosen for 
more extensive spectroscopic analysis (spectra i – iv). Interestingly, the spectra of i, iii, and iv 
showed  a  peak  around  700  nm,  consistent  with  the  approximate  spectral  resonance  and 
intensity of single hollow gold NPs as determined from the correlative transmission electron 
microscopy  study.  Furthermore,  the  spectrum  obtained  for  the  bright  spot  area  ii  had  a 
complex red-shifted response –compared to the individual NPs- as expected for a typical 
response for a group of two or more NPs.  
 
 
Figure 4.17. A. Darkfield image at 713 nm, and B. a combined false colour image showing darkfield, DAPI 
fluorescence and brightfield images of a SH-SY5Y cell that has been incubated with hollow gold nanoparticles 
for 1 h are shown along with spectra (i)–(iv), taken from different bright spots indicated on the darkfield image. 
Integration time: 0.1 s per image. Images taken from [41]. Chapter 4. Interaction of gold NPs with neurons  38 
The  interaction  of  NPs  and  their  uptake  by  the  cell-as  mention  in  previous  chapters- 
depends on the capping and functionalization of their surface area. For example, NPs that are 
OEG-capped when exposed to cells are taken up by cells non-specifically. On the other hand, 
NPs that are functionalised with a cell specific binding peptide, such as the Tet1, possibly a 
receptor-mediated endocytosis is promoted.  
 
 
Figure 4.18. A. Darkfield image at 713 nm, and B. a combined false colour image showing darkfield, DAPI 
fluorescence and brightfield images of a control SH-SY5Y cell that was not been incubated with hollow gold 
nanoparticles are shown along with spectra (i)–(iv), taken from different bright spots indicated on the darkfield 
image. Integration time: 0.1 s per image. Images taken from [41]. 
In Figure 4.18, looking at the image of the cell which was not incubated with hollow gold 
NPs (control sample), there was some intensity when the sample was viewed in darkfield. 
However, the intensity was lower and smooth over the control sample, without any sharp 
features present. This light intensity could be attributed to the light intensity scattered from 
the cell itself. The spectra i-iv shown in Figure 4.18, do not have the characteristic peaks of 
NP resonances and are about five times lower than the signals obtained from single NPs. 
Therefore, this light intensity can be clearly differentiated from the NP signals. 
The results obtained from this study suggest that the peptide-functionalised NPs seemed to 
interact  with  the  cells  after  a  short  time  of  incubation,  compared  to  the  control  sample. 
However, at this point no conclusion can be drawn where exactly the NPs are found relative 
to the cell, henceforth, more experiments are required, whereby the cytoskeleton of the cell 
together with a few subcellular organelles could be fluorescently labelled. Chapter 4. Interaction of gold NPs with neurons  39 
Furthermore, the illumination intensity used was considered to be low (<0:5 W/cm
2) and 
safe to be used for future studies with living cells and metallic NPs [10]. In addition, a 
different investigation could be conducted using single hollow gold NPs as spectral sensors 
of a particular activity within the cell, for example for studying a specific cell signalling 
pathway [54]. 
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In the last few decades, advances in nanoscience have resulted in the production and use of 
inorganic  NPs.  These  NPs  have  been  used  commercially  for  a  range  of  applications, 
particularly  in  the  biomedical  field,  based  on  their  exceptional  chemical  and  physical 
properties, which are very different to that in the larger scale (see Chapter 2). 
Nevertheless, in order to encourage the use of inorganic NPs in our everyday life, and 
more specifically in the clinical setting, our understanding regarding the NP interaction with 
the cells following NP exposure, it is very important [9]. This was the motivation for the 
work carried out in this thesis, as described in Chapter 1.  
Firstly, this investigation involved the synthesis of spherical and hollow gold NPs (see 
Sections 2.4 and 3.1) which were then capped with water soluble organic ligands, such as 
OEG.  The  resulting  OEG-capped  NPs  were  then  functionalised  by  attaching  a  specific 
targeting peptide, lysine terminated-Tet1, on their organic corona (see Sections 2.5 and 3.2). 
The surface modification of the NPs by the aforementioned ligands, was carried out so that 
the NPs could be employed in the biological investigations carried out in this work.  
Two types of neuron-like cell lines were employed, PC12 and SH-SY5Y cells, which are 
considered  to  be  good  models  for  neurobiological  investigations  and  share  many 
characteristics with primary neurons. These neuron-like cells were exposed to the synthesised 
gold NPs, and the fate of these NPs within the cells was studied by using imaging techniques, 
such  as  transmission  electron  (see  Sections  4.3  and  4.4)  and  hyperspectral  darkfield 
microscopy (see Section 4.5). 
In Section 4.3 it was shown from the TEM images that spheres and hollow gold NPs were 
found  within  the  PC12  cells,  indicating  that  they  were  able  to  traverse  through  the  cell 
membrane.  Nevertheless,  the  pathway  and  cellular  processes  involved  could  not  be 
specifically  defined  at  this  stage  of  the  investigation.  Further  and  extensive  studies  will 
enable us to create a complete profile regarding the cellular pathways involved in cellular 
uptake, distribution, as well as, exocytosis of NPs. 
Furthermore,  the  investigation  about  the  interaction  of  PC12  cells  with  peptide 
functionalised spherical gold NPs was presented in Section 4.4. The peptide functionalised 
NPs were used to target the GTb1 receptors that are expressed readily on the neuron-cell 
lines employed in this project. The uptake and distribution of the lysine terminated Tet1-Chapter 5. Conclusions  43 
functionalised  NPs  and  OEG-capped  NPs  were  different.  Lysine  terminated  Tet1-
functionalised NPs uptake seemed to be greater compared to OEG-capped NPs, and they 
were transported to the inner part of the cell around its perinuclear region. A study using 
images obtained from TEM, can give solid evidence on the location of the NPs relative to the 
cell (as the cell with its sub-cellular structures can be clearly distinguished). On the other 
hand, a TEM study with various factors under investigation would be time consuming, and 
within  the  time  frame  of  this  thesis  it  was  not  possible.  Therefore,  future  experiments 
involving fluorescently tagged NPs would give us an inside on the cellular events that take 
place following NP exposure, over time. In addition, imaging techniques of non-fluorescent 
metallic  NPs  could  be  employed,  such  as  the  hyperspectral  darkfield  microscopy  shown 
earlier in Section 4.5. Furthermore, western blot analysis of proteins involved in a cell stress 
response could be conducted in future experiments. Such an investigation would show us 
whether the cell is under a stress when it is exposed to gold NPs, and how the cell deals with 
such an ‘insult’ overtime. 
The application of the hyperspectral darkfield microscope designed by the Muskens group 
for imaging of single hollow gold NPs on a TEM grid and in a biological sample with fixed 
SH-SY5Y cells, was also presented in this Thesis. The illumination intensity used was <0:5 
W/cm
2, which is considered to be a very positive parameter for future studies with living 
cells and metallic NPs [10]. In addition, more and different investigations could be conducted 
with  single hollow gold NPs  that could  serve as  spectral  sensors of  a  particular activity 
within the cell, in order to shed some light in the events taking place during, for example a 
cell signalling pathway [54]. 
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Appendix 
A1. Spherical manganese ferrite nanoparticles 
Manganese ferrite NPs were prepared by a modified method developed by Sun [55]. Iron 
(III) acetyl acetoate (0.70 g), manganese (II) acetyl acetoate (0.30 g), 1, 2 hexadecanediol 
(2.50 g), dodecylamine (1.27 g), lauric acid (1.10 g) and benzyl ether (20 ml) were mixed at 
140 
oC and under nitrogen, until they were completely dissolved. The reaction mixture was 
vigorously mixed at 140 
oC for one hour (step one), then at 210 
oC for two hours (step two; 
nucleation step) and finally at 300 
oC for one hour (step three). The colour of the reaction 
mixture  changed  from  bright  red  to  dark  brown.  Once  the  reaction  was  completed  the 
solution was poured into ice-cold glass vials filled with ethanol, isopropanol and acetone, and 
was centrifuged for 20 minutes (1000 rcf). The ethanol and isopropanol were used to dissolve 
the  surfactant  and  the  acetone  to  precipitate  the  NPs.  The  sample  was  purified  by  three 
further  centrifugation/decantation  steps.  Acetone,  isopropanol  and  ethanol  were  used  to 
redisperse the pellet, except in the final purification step where toluene, was added. ICP-MS 
was used to quantify the concentration of the NPs. 
The manganese ferrite NPs were transferred to water by coating their outer surface with 
poly(maleic anhydride-alt-1-octadecene) (the polymer). The NP: polymer ratio was 1:10. The 
NPs were precipitated using acetone. Then chloroform was added to dissolve the NPs and 
was evaporated under vacuum. Chloroform was added again in order to dissolve the NPs and 
the solution was sonicated at room temperature, for twenty minutes. The polymer solution 
(134 mM) was then added to the NPs. Another evaporation/dissolution step was carried out. 
The NPs were dissolved in borate buffer (pH 9) and the solution was sonicated at room 
temperature,  for  three  hours.  Once  fully  dissolved,  the  NP  solution  was  precipitated  by 
centrifugation  (1500  rcf,  30  minutes)  using  100  kDa  molecular  weight  cut-off 
ultracentrifugation filtration membranes.  
After the polymer coating, 0.5 mL of NPs solution was added to an ultracentrifuge tube 
with a sucrose gradient of 10 % to 60 %. The NP solution was separated from the free excess 
polymer into different bands by ultracentrifugation (25 000 rcf; 3 ½ h; 4 
oC). The purified NP Appendix  52 
solution band was extracted using a syringe and was further purified from sucrose by four 
purification steps (2 100 rcf; 12 minutes per step) using 100 kDa molecular weight cut-off 
ultracentrifugation filtration membranes. Borate buffer, pH 9, was added in each step. 
 In order to identify any free polymer present in the NP solution, gel electrophoresis was 
performed (60min; 100 mV; 1% agarose gel; 0.5x TBE buffer, pH 8). 
A1.2. Manganese ferrite nanoparticles: Characterisation 
The iron manganese oxide NPs were spherical (Figure A1.1) with an average size of 8 nm. 
Their size was altered by changing the time point and temperature of the nucleation step 
(second step) during the chemical synthesis. A delayed nucleation step or higher temperature 
(>210 
oC) resulted in the formation of smaller NPs. The molar concentration of each element 
present in iron manganese oxide NPs, was determined by ICP-MS (before and after polymer 
coating). Furthermore, the purity of a polymer coated NP sample was qualitatively examined 
using electrophoretic analysis.  
 
Figure A.1.1 A TEM image of FeMnO nanoparticle solution in toluene; scale bar = A: 20 nm and B: 10 nm. 
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Figure A.1.2. Size distribution of the manganese ferrite NPs. 
 
Figure A.1.3. Electrophoretic analysis of polymer coated, ultrapurified iron manganese oxide nanoparticles. 
A2. Immunohistochemistry of beta-tubulin 
The  beta-tubulin  in  the  cell  cytoskeleton  was  fluorescently  labelled  with 
immunohistochemical techniques. The cells were washed twice with pre-warmed PBS and 
then fixed with 4 % PFA in PBS for 15 minutes (at room temperature). These were then 
washed three times with PBS-Tween (0.001 %), and blocked with 5 % normal goat serum for 
30 minutes (at room temperature). The blocking solution was aspirated and the goat mouse 
beta tubullin primary antibody (prepared in 0.25 % normal goat serum, PBS-Tween, 1: 200) 
was  added to  the samples  and left overnight  (at  4 
oC). The next  day,  the samples  were 
washed three times with PBS-Tween (five minutes per wash). The secondary antibody, goat 
anti-mouse 488 nm (prepared in 0.25 % NGS, PBS-Tween) was added (in 1: 200) to the 
samples. Then the samples were washed and then mounted with DAPI and left to dry for 
approximately 24 hours (at room temperature in the dark).  
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